1. Home
  2. CALC vs ECDA Comparison

CALC vs ECDA Comparison

Compare CALC & ECDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • ECDA
  • Stock Information
  • Founded
  • CALC 2011
  • ECDA 2013
  • Country
  • CALC United States
  • ECDA United States
  • Employees
  • CALC N/A
  • ECDA N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • ECDA Auto Manufacturing
  • Sector
  • CALC Health Care
  • ECDA Consumer Discretionary
  • Exchange
  • CALC Nasdaq
  • ECDA Nasdaq
  • Market Cap
  • CALC 22.9M
  • ECDA 11.5M
  • IPO Year
  • CALC N/A
  • ECDA N/A
  • Fundamental
  • Price
  • CALC $1.61
  • ECDA $0.29
  • Analyst Decision
  • CALC Strong Buy
  • ECDA
  • Analyst Count
  • CALC 3
  • ECDA 0
  • Target Price
  • CALC $16.33
  • ECDA N/A
  • AVG Volume (30 Days)
  • CALC 30.2K
  • ECDA 14.4M
  • Earning Date
  • CALC 08-11-2025
  • ECDA 08-18-2025
  • Dividend Yield
  • CALC N/A
  • ECDA N/A
  • EPS Growth
  • CALC N/A
  • ECDA N/A
  • EPS
  • CALC N/A
  • ECDA N/A
  • Revenue
  • CALC N/A
  • ECDA $24,597,358.00
  • Revenue This Year
  • CALC N/A
  • ECDA $21.59
  • Revenue Next Year
  • CALC N/A
  • ECDA N/A
  • P/E Ratio
  • CALC N/A
  • ECDA N/A
  • Revenue Growth
  • CALC N/A
  • ECDA 3.46
  • 52 Week Low
  • CALC $1.42
  • ECDA $0.24
  • 52 Week High
  • CALC $5.97
  • ECDA $1.35
  • Technical
  • Relative Strength Index (RSI)
  • CALC 47.03
  • ECDA 41.91
  • Support Level
  • CALC $1.42
  • ECDA $0.25
  • Resistance Level
  • CALC $1.85
  • ECDA $0.30
  • Average True Range (ATR)
  • CALC 0.15
  • ECDA 0.06
  • MACD
  • CALC -0.00
  • ECDA -0.00
  • Stochastic Oscillator
  • CALC 44.19
  • ECDA 4.86

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About ECDA ECD Automotive Design Inc.

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

Share on Social Networks: